Results 1 to 10 of about 522,540 (304)
Isoprostanoids in Clinical and Experimental Neurological Disease Models [PDF]
Antioxidants, 2018 Isoprostanoids are a large family of compounds derived from non-enzymatic oxidation of polyunsaturated fatty acids (PUFAs). Unlike other oxidative stress biomarkers, they provide unique information on the precursor of the targeted PUFA.
Cinzia Signorini +9 more
doaj +11 more sources
Porcine Models of Neurotrauma and Neurological Disorders [PDF]
BiomedicinesThe translation of therapeutics from lab to clinic has a dismal record in the fields of neurotrauma and neurological disorders [...]
John C. O’Donnell, Dmitriy Petrov
doaj +4 more sources
Neurorobotic Models of Neurological Disorders: A Mini Review [PDF]
Frontiers in Neurorobotics, 2021 Modeling is widely used in biomedical research to gain insights into pathophysiology and treatment of neurological disorders but existing models, such as animal models and computational models, are limited in generalizability to humans and are restricted
Savva Pronin +5 more
doaj +2 more sources
Unraveling pathological mechanisms in neurological disorders: the impact of cell-based and organoid models [PDF]
Neural Regeneration Research, 2022 Cell-based models are a promising tool in deciphering the molecular mechanisms underlying the pathogenesis of neurological disorders as well as aiding in the discovery and development of future drug therapies.
Jake Langlie +7 more
doaj +2 more sources
Animal Models of Neurological Disorders: Where Are We Now? [PDF]
Biomedicines, 2023 The Special Issue “Animal Models of Neurological Disorders: Where Are We Now [...]
Sandesh Panthi, Marc Ekker
doaj +2 more sources
Alzheimer’s Research & Therapy, 2022 Background Gangliosides are highly enriched in the brain and are critical for its normal development and function. However, in some rare neurometabolic diseases, a deficiency in lysosomal ganglioside hydrolysis is pathogenic and leads to early-onset ...
James C. Dodge +7 more
doaj +1 more source
Animal Models of Neurological Disorders [PDF]
Neurotherapeutics, 2012 The discovery of new therapies for neurological disorders is predicated on the use of animal models both to identify new therapeutic targets and to perform preclinical trials of drugs before using them in patients. In both cases, the challenge is to develop models that recapitulate the disorder.
Marie-Francoise, Chesselet +1 more
openaire +2 more sources
Cerebellar dysfunction in rodent models with dystonia, tremor, and ataxia
Dystonia, 2023 Dystonia is a movement disorder characterized by involuntary co- or over-contractions of the muscles, which results in abnormal postures and movements. These symptoms arise from the pathophysiology of a brain-wide dystonia network.
Meike E. van der Heijden +6 more
doaj +1 more source
Medicina, 2019 Background and Objectives: The knowledge that the cholinergic neurons from pedunculopontine nucleus (PPN) are vulnerable to the degeneration in early stages of the Parkinson disease progression has opened new perspectives to the development of ...
Lisette Blanco-Lezcano +9 more
doaj +1 more source
CHANGING PERSPECTIVE ON PERCEPTION PHYSIOLOGY: CAN YOU REALLY SEE WHAT IS HAPPENING?
Euromediterranean Biomedical Journal, 2018 Perception is a complex, neural mechanism that requires organization and interpretation of input meaning and it has been a key topic in medicine, neuroscience and philosophy for centuries.
Giuseppe Giglia
doaj +1 more source